Kura Oncology, Inc. Quarterly Nonoperating Income (Expense) in USD from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Kura Oncology, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q4 2014 to Q3 2024.
  • Kura Oncology, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $5.48M, a 41.6% increase year-over-year.
  • Kura Oncology, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $20M, a 77.5% increase year-over-year.
  • Kura Oncology, Inc. annual Nonoperating Income (Expense) for 2023 was $13.2M, a 227% increase from 2022.
  • Kura Oncology, Inc. annual Nonoperating Income (Expense) for 2022 was $4.03M, a 408% increase from 2021.
  • Kura Oncology, Inc. annual Nonoperating Income (Expense) for 2021 was $792K, a 65.2% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $20M $5.48M +$1.61M +41.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $18.3M $5.57M +$2.74M +96.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $15.6M $4.93M +$2.43M +97.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $13.2M $3.98M +$1.93M +94.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $11.2M $3.87M +$2.78M +255% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $8.46M $2.83M +$2.27M +402% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $6.19M $2.5M +$2.17M +659% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $4.03M $2.04M +$1.75M +592% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $2.28M $1.09M +$779K +250% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $1.5M $564K +$580K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $919K $329K +$127K +62.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $792K $295K +$122K +70.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $670K $311K -$114K -26.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $784K -$16K -$702K -102% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $1.49M $202K -$788K -79.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $2.27M $173K -$925K -84.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $3.2M $425K -$857K -66.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $4.06M $686K -$262K -27.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $4.32M $990K -$21K -2.08% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $4.34M $1.1M +$561K +104% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $3.78M $1.28M +$307K +31.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $3.47M $948K +$411K +76.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $3.06M $1.01M +$624K +161% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 $2.44M $537K +$290K +117% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-24
Q3 2018 $2.15M $975K +$809K +487% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $1.34M $537K +$427K +388% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $910K $387K +$267K +223% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $643K $247K +$116K +88.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $527K $166K +$34K +25.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 $493K $110K -$20K -15.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $513K $120K -$294K -71% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $807K $131K -$237K -64.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 $1.04M $132K -$206K -60.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $1.25M $130K -$192K -59.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $1.44M $414K +$202K +95.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $1.24M $368K +$105K +39.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 $1.14M $338K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $322K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $212K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 $263K Aug 22, 2014 Dec 31, 2014 10-K 2016-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.